• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Medline Inc.

    2/13/26 6:19:21 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care
    Get the next $MDLN alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Medline Inc.

    (Name of Issuer)


    Class A common stock, par value $0.0001 per share

    (Title of Class of Securities)


    58507V107

    (CUSIP Number)


    12/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    58507V107


    1Names of Reporting Persons

    Hellman & Friedman Capital Partners X (Parallel), L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    85,733,022.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    85,733,022.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    85,733,022.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.2 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    58507V107


    1Names of Reporting Persons

    HFCP X (Parallel - A), L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    8,955,577.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    8,955,577.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    8,955,577.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    1.0 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    58507V107


    1Names of Reporting Persons

    Mend Partners II, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    4,806,160.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    4,806,160.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    4,806,160.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0.5 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    58507V107


    1Names of Reporting Persons

    Mend Investment Holdings I, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    115,808,277.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    115,808,277.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    115,808,277.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    12.5 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    58507V107


    1Names of Reporting Persons

    Hellman & Friedman Investors X, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    215,303,036.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    215,303,036.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    215,303,036.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    23.2 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    58507V107


    1Names of Reporting Persons

    Mend Partners GP, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    4,806,160.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    4,806,160.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    4,806,160.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0.5 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    58507V107


    1Names of Reporting Persons

    Mend Investment Holdings GP, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    115,808,277.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    115,808,277.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    115,808,277.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    12.5 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    58507V107


    1Names of Reporting Persons

    Hellman & Friedman Capital Partners X, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    115,808,277.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    115,808,277.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    115,808,277.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    12.5 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    58507V107


    1Names of Reporting Persons

    H&F Corporate Investors X, Ltd.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    215,303,036.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    215,303,036.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    215,303,036.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    23.2 %
    12Type of Reporting Person (See Instructions)

    CO


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Medline Inc.
    (b)Address of issuer's principal executive offices:

    3 Lakes Drive, Northfield, Illinois 60093
    Item 2. 
    (a)Name of person filing:

    Each of the following is hereinafter referred to as a "Reporting Person" and collectively as the "Reporting Persons." This statement is filed on behalf of: (i) Hellman & Friedman Capital Partners X (Parallel), L.P., a Cayman Islands exempted limited partnership ("HFCP X Parallel") (ii) HFCP X (Parallel - A), L.P., a Delaware limited partnership ("HFCP X Parallel-A") (iii) Mend Partners II, L.P., a Delaware limited partnership ("Mend Partners II") (iv) Mend Investment Holdings I, L.P., a Delaware limited partnership ("Mend Investment I") (v) Hellman & Friedman Investors X, L.P., a Cayman Islands exempted limited partnership ("Investors X GP") (vi) Mend Partners GP, LLC, a Delaware limited liability company ("Mend GP") (vii) Mend Investment Holdings GP, LLC, a Delaware limited liability company ("Mend Investment GP") (viii) Hellman & Friedman Capital Partners X, L.P., a Cayman Islands exempted limited partnership ("HFCP X") (ix) H&F Corporate Investors X, Ltd., a Cayman Islands exempted company ("Investors X Ltd.") Investors X GP is the general partner of HFCP X Parallel and HFCP X Parallel-A. Mend GP is the general partner of Mend Partners II. Investors X GP is the managing member of Mend GP. Mend Investment GP is the general partner of Mend Investment I. HFCP X is the managing member of Mend Investment GP. Investors X GP is the general partner of HFCP X. Investors X Ltd. is the general partner of Investors X GP.
    (b)Address or principal business office or, if none, residence:

    The principal business address of each of the Reporting Persons is c/o Hellman & Friedman LLC, 415 Mission Street, Suite 5700, San Francisco, CA 94105
    (c)Citizenship:

    See Item 2(a)
    (d)Title of class of securities:

    Class A common stock, par value $0.0001 per share
    (e)CUSIP No.:

    58507V107
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    The information contained in rows 5, 6, 7, 8, 9, 10, and 11 on each of the cover pages of this Schedule 13G is incorporated by reference into this Item 4. As of the date hereof, the Reporting Persons may be deemed to beneficially own an aggregate of 215,303,036 shares of the Class A common stock of Medline Inc. (the "Class A Common Stock"), consisting of (i) 85,733,022 shares of the Class A Common Stock held by HFCP X Parallel, (ii) 8,955,577 shares of Class A Common Stock held by HFCP X Parallel-A, (iii) 4,806,160 shares of Class A Common Stock held by Mend Partners II, (iv) 19,310 shares of Class A Common Stock held by Mend Investment I, and (v) 115,788,967 shares of Class A Common Stock issuable to Medline Investment I upon exchange for an equal number of the common units of Medline Holdings L.P. (the "Common Units") held by Medline Investment I. The Common Units held by Mend Investment I are paired with an equal number of shares of the Class B common stock of Medline Inc. (the "Class B Common Stock"). Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders of Common Units have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and re-classifications. These exchange rights do not expire. Shares of the Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon an exchange of Common Units for shares of the Class A Common Stock, an equivalent number of shares of Class B Common Stock held by such holder will be automatically cancelled. Mend GP is the general partner of Mend Partners II and may, as a result, be deemed to beneficially own the 4,806,160 shares of Class A Common Stock beneficially owned by Mend Partners II. Mend Investment GP is the general partner of Mend Investment I and HFCP X is the managing member of Mend Investment GP and, as a result, each of Mend Investment GP and HFCP X may be deemed to beneficially own the 115,808,277 shares of Class A Common Stock beneficially owned by Mend Investment I. Investors X GP is the managing member of Mend GP and the general partner of each of HFCP X Parallel, HFCP X Parallel-A and HFCP X as, as a result, may be deemed to beneficially own an aggregate of 215,303,036 shares of Class A Common Stock beneficially owned by such entities. Investors X Ltd. is the general partner of Investors X GP and may, as a result, be deemed to beneficially own the 215,303,036 shares of Class A Common Stock beneficially owned by Investors X GP. A three-member board of directors of Investors X Ltd. has voting and investment discretion over the securities held by HFCP X Parallel, HFCP X Parallel-A, Mend Partners II., and Mend Investment I. Each of the members of the board of directors of Investors X Ltd. disclaims beneficial ownership of such shares.
    (b)Percent of class:

    The ownership percentages reflected in this Schedule 13G are calculated based on (i) 811,418,179 shares of Class A Common Stock outstanding as reported in the Issuer's Final Prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on December 18, 2025, following the underwriters' exercise in full of their option to purchase additional shares of Class A Common Stock, (ii) plus 2,098,005 shares of Class A Common Stock issued to Mend Investment I on December 18, 2025 in exchange for an equal number of Common Units, plus (iii) the 115,788,967 shares of Class A Common Stock issuable to the Reporting Persons upon exchange of Common Units.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See row 5 on each of the cover pages of this Schedule 13G.

     (ii) Shared power to vote or to direct the vote:

    See row 6 on each of the cover pages of this Schedule 13G.

     (iii) Sole power to dispose or to direct the disposition of:

    See row 7 on each of the cover pages of this Schedule 13G.

     (iv) Shared power to dispose or to direct the disposition of:

    See row 8 on each of the cover pages of this Schedule 13G.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    Not Applicable

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Hellman & Friedman Capital Partners X (Parallel), L.P.
     
    Signature:/s/ Jacob Best
    Name/Title:Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
    Date:02/13/2026
     
    HFCP X (Parallel - A), L.P.
     
    Signature:/s/ Jacob Best
    Name/Title:Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
    Date:02/13/2026
     
    Mend Partners II, L.P.
     
    Signature:/s/ Jacob Best
    Name/Title:Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
    Date:02/13/2026
     
    Mend Investment Holdings I, L.P.
     
    Signature:/s/ Jacob Best
    Name/Title:Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
    Date:02/13/2026
     
    Hellman & Friedman Investors X, L.P.
     
    Signature:/s/ Jacob Best
    Name/Title:Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
    Date:02/13/2026
     
    Mend Partners GP, LLC
     
    Signature:/s/ Jacob Best
    Name/Title:Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
    Date:02/13/2026
     
    Mend Investment Holdings GP, LLC
     
    Signature:/s/ Jacob Best
    Name/Title:Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
    Date:02/13/2026
     
    Hellman & Friedman Capital Partners X, L.P.
     
    Signature:/s/ Jacob Best
    Name/Title:Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
    Date:02/13/2026
     
    H&F Corporate Investors X, Ltd.
     
    Signature:/s/ Jacob Best
    Name/Title:Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
    Date:02/13/2026
    Exhibit Information

    Exhibit 99.1 - Signatures of the Reporting Persons Exhibit 99.2 - Joint Filing Agreement, by and among, the Reporting Persons, dated as of Febuary 13, 2026

    Get the next $MDLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDLN

    DatePrice TargetRatingAnalyst
    2/5/2026$55.00Buy
    Tigress Financial
    1/21/2026$50.00 → $55.00Buy
    BTIG Research
    1/12/2026$48.00Buy
    Citigroup
    1/12/2026$38.00Neutral
    BNP Paribas Exane
    1/12/2026$50.00Overweight
    Analyst
    1/12/2026$50.00Overweight
    Piper Sandler
    1/12/2026$48.00Overweight
    Morgan Stanley
    1/12/2026$47.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $MDLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tigress Financial initiated coverage on Medline with a new price target

    Tigress Financial initiated coverage of Medline with a rating of Buy and set a new price target of $55.00

    2/5/26 10:03:24 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    BTIG Research reiterated coverage on Medline with a new price target

    BTIG Research reiterated coverage of Medline with a rating of Buy and set a new price target of $55.00 from $50.00 previously

    1/21/26 1:17:48 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Citigroup initiated coverage on Medline with a new price target

    Citigroup initiated coverage of Medline with a rating of Buy and set a new price target of $48.00

    1/12/26 10:44:50 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gic Private Ltd sold $289,480,090 worth of shares (10,204,351 units at $28.37) and bought $364,999,974 worth of shares (12,586,206 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 5:26:57 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Mills Andrew J. was granted 30,655 units of Class B Common Stock and bought $74,999,974 worth of shares (2,586,206 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 4:30:06 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Mills Charles N. was granted 64,005 units of Class B Common Stock and bought $74,799,990 worth of shares (2,579,310 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 4:30:04 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medline to report fourth quarter and full year 2025 results on February 25, 2026

    NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedli

    1/28/26 9:00:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

    NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, January 13, 2026, at 3:00 pm Pacific Time. The presentation will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available on Medline's Investor Relations website for 30 days following the event. About MedlineMedline is the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all point

    12/30/25 4:05:00 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

    NORTHFIELD, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its upsized initial public offering of 248,439,654 shares of its Class A common stock at a public offering price of $29.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 32,405,172 shares of Class A common stock. Medline intends to use the proceeds (net of underwriting discounts) from the issuance of 179,000,000 shares to repay outstanding indebtedness under its senior secured term loan facilities and the remainder for general corporate purposes and to bear the expenses of the offering. Medline intends to

    12/18/25 4:05:00 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Medline Inc.

    SCHEDULE 13G - Medline Inc. (0002046386) (Subject)

    2/13/26 6:19:21 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by Medline Inc.

    SCHEDULE 13G - Medline Inc. (0002046386) (Subject)

    2/13/26 4:30:02 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by Medline Inc.

    SCHEDULE 13G - Medline Inc. (0002046386) (Subject)

    2/13/26 4:30:05 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Carlyle Mozart Coinvestment Unlv Holdco, L.P. claimed ownership of 15,417,129 shares and claimed ownership of 15,369,974 units of Class B Common Stock (SEC Form 3)

    3 - Medline Inc. (0002046386) (Issuer)

    2/13/26 4:30:19 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Large owner Carlyle Mozart Coinvestment Holdings, L.P. disposed of 15,414,514 shares, decreasing direct ownership by 49% to 16,125,094 units (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    2/13/26 4:30:06 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Former 10% Owners Cp Circle Holdings, L.P. disposed of 2,615 shares and disposed of 15,369,974 units of Class B Common Stock, closing all direct ownership in the company (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    2/13/26 4:30:08 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Financials

    Live finance-specific insights

    View All

    Medline to report fourth quarter and full year 2025 results on February 25, 2026

    NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedli

    1/28/26 9:00:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care